Enveric Biosciences Files 8-K for Regulation FD and Financials
Ticker: ENVB · Form: 8-K · Filed: Feb 29, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Feb 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, disclosure
TL;DR
**Enveric Biosciences just dropped an 8-K for Regulation FD and financials, keeping investors in the loop.**
AI Summary
Enveric Biosciences, Inc. filed an 8-K on February 29, 2024, to disclose information under Regulation FD and provide financial statements and exhibits. The filing indicates a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company, incorporated in Delaware with IRS Number 95-4484725, maintains its principal executive offices at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
Why It Matters
This filing provides updated public information about Enveric Biosciences, ensuring transparency and compliance with SEC regulations, which can influence investor perception and market activity.
Risk Assessment
Risk Level: low — This is a routine disclosure filing and does not inherently indicate significant risk or opportunity.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- Delaware (location) — State of incorporation
- 95-4484725 (number) — IRS Employer Identification No.
- 4851 Tamiami Trail N, Suite 200, Naples, FL 34103 (location) — Principal executive offices
- February 29, 2024 (date) — Date of report
FAQ
What is the purpose of Enveric Biosciences, Inc.'s 8-K filing on February 29, 2024?
The 8-K filing by Enveric Biosciences, Inc. on February 29, 2024, is for Regulation FD Disclosure and to provide Financial Statements and Exhibits.
Under which section of the Securities Exchange Act of 1934 was this report filed?
This report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Where are Enveric Biosciences, Inc.'s principal executive offices located?
Enveric Biosciences, Inc.'s principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the state of incorporation for Enveric Biosciences, Inc.?
Enveric Biosciences, Inc. is incorporated in Delaware.
What is the Commission File Number for Enveric Biosciences, Inc.?
The Commission File Number for Enveric Biosciences, Inc. is 001-38286.
Filing Stats: 594 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-02-29 07:00:24
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 9KB
- 0001493152-24-008264.txt ( ) — 243KB
- envb-20240229.xsd (EX-101.SCH) — 3KB
- envb-20240229_lab.xml (EX-101.LAB) — 33KB
- envb-20240229_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 29, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer